Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 40th Annual Strategic Decisions Conference on Thursday, May 30, 2024, at 2:30PM ET.

Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference

TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it has terminated its agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the “Peace Naturals Campus”). The Buyer did not satisfy or waive its due diligence and financing condition by the May 27, 2024 deadline, as set forth in the Sale Agreement. All amounts paid by the Buyer as part of a security deposit that were previously held in trust have been returned, in accordance with the Sale Agreement. The Company is continuing to evaluate its strategic options for the Peace Naturals Campus, which may include continuing and expanding operations at the facility.

Cronos Terminates Sale-Leaseback of Peace Naturals Campus

Curaleaf Holdings, Inc.

Tilray Brands

I have talked about cannabis stocks to buy in several instances in the last few quarters. However, the timing for exposure couldn't be better than now for several reasons.

Schedule III Windfall: 3 Stocks to Buy BEORE the Cannabis Reclassification

Lithium Americas Corp

Solid Power

Investors largely look at penny stocks to buy from a trading or speculation perspective. The idea is to sell when the stock doubles or triples.

3 Penny Stocks That Could Be Millionaire-Makers: May Edition

Blink Charging

Riot Blockchain

The meme stock rally of 2021 will go down in the books of financial history as one of the craziest periods of euphoria. The big meme stock rally was followed by an extended period of correction for speculative stocks.

Laugh Your Way to the Bank: 3 Meme Stocks to Buy as the Mania Returns

Coupang

DraftKings

Li Auto Inc.

MakeMyTrip

MINISO Group Holding

The single biggest quality of an investor that can make him/her a millionaire is patience. With some research, it's not difficult to spot quality growth stocks to buy.

7 Growth Stocks to Buy Now for 20X Returns by 2030

Archer Aviation

Bitfarms Ltd

IAMGOLD

Plug Power

Ring Energy

Wallbox NV

When policymakers pursue rate cuts, the main idea is to lower the cost of money for businesses and consumers. This translates into higher investment and consumption spending and GDP growth accelerates.

7 Penny Stocks to Buy for 100% Returns on Potential Policy Shifts

Aurora Cannabis

Canopy Growth

AdvisorShares Pure US Cannabis ETF

Cannabis stocks are once again on the move today, with some big names being seen across the sector. Shares of Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ), Aurora Cannabis (NASDAQ: ACB ), AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ), and Cronos (NASDAQ: CRON ) are all up between 2% and 10% in today's session, with Canopy Growth leading the way higher.

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling

Mastercard

PayPal

Visa

When Ellis Soodak was planning the launch of Verdi Cannabis dispensary in New York City, he didn't want to face the dangers his father did at the family's liquor store in the 1970s and 80s.

Card payments remain a ‘challenge' for legal cannabis as major banks avoid the sector. Changing classification won't help.

Greenlane Holdings

As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis investments. This year could mark a significant turning point with the potential rescheduling of cannabis at the federal level. If cannabis can one day be federally legal it would be the biggest win for the industry.

This Is How Marijuana Stocks Will Be Impacted By Reform In 2024

My view is that expansionary monetary policy in the second half of 2024 is likely to be a major catalyst for a broad-based market rally. It's therefore a good time to accumulate high-quality growth stocks.

7 Massively Undervalued Penny Stocks to Buy for 7-Bagger Returns

Jazz Pharmaceuticals

Leafly Holdings

Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.

7 Cannabis Stocks to Buy for a Smoking-Hot 2024

Shares of Cronos Group Inc. CRON CA:CRON climbed 3.1% in premarket trading, after the cannabis company reported revenue that rose to a record and beat expectations, citing strength in flower sales in Canada and Israel. The company reported a net loss of $24.7 million, or 1 cent a share, after a loss of $16.8 million, or 5 cents a share, in the same period a year ago, to match the FactSet consensus for per-share losses of 1 cent.

Cronos' stock rallies after revenue rises to a record, amid strength in cannabis flower sales

Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach ® was top-3 in retail sales in Canada in the flower, edible, and vape categories in Q1 2024 Launched PEACE NATURALS ® brand in the United Kingdom in May 2024 TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2024 first quarter business results. “Cronos achieved its highest quarterly net revenue from continuing operations on record at $25.3 million, up 30% year-over-year.

Cronos Group Reports 2024 First Quarter Results

Joby Aviation

The rules of investing have significantly changed over the years. That particularly holds true for investors looking for short-term gains.

The 3 Best Meme Stocks to Buy in May 2024

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding its medical brand, PEACE NATURALS, into the United Kingdom market with its first shipment of cannabis flower to GROW® Pharma, a leading distributor of prescribed medicinal cannabis products in the UK.

Cronos Enters United Kingdom Cannabis Market

AdvisorShares Pure Cannabis ETF 

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

High Tide

Village Farms International

As May 2024 begins, Canadian cannabis companies are catching the eye of savvy investors. Among these, Canopy Growth Corporation and Aurora Cannabis stand out for their expansive market reach and innovation. These companies have been pioneers in the cannabis industry, expanding their operations globally. They are well-positioned to capitalize on emerging markets. This is due to their early entry and continuous investment in research and development.

May 2024 Watchlist: Leading Canadian Cannabis Stocks Poised for Growth

The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.

Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered

Canopy Growth Corp. and Tilray Brands Inc. stocks made more modest moves on Wednesday after a huge rally in the previous session on plans by the Biden administration to reclassify pot as less dangerous under federal law.

Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous

Warren Buffett is a well-known proponent of value investing. The legendary investor waits for the right valuation before making a big plunge.

Stock Market Crash Alert: 3 Must-Buy Cannabis Stocks When Prices Plunge

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

SNDL Inc.

The DEA officially agreed to recommend rescheduling cannabis from a Class I to a Class III drug. While it doesn't legalize cannabis, the measure has the potential to be hugely impactful to U.S. multi-state operators.

Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

News for Cronos Group Stock (CRON)